Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
6. GLOBAL ANTIEMETICS MARKET, BY AGENTS
6.1. Overview
6.2. Dopamine Antagonists
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.2.1. Phenothiazines
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.2.1.1. Chlorpromazine
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.2.1.2. Prochlorperazine
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.2.2. Butyrophenones
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.2.2.1. Droperidol
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.2.2.2. Domperidone
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.2.3. Benzamides
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.3. Anticholinergics
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.4. Antihistamines
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.5. Serotonin Antagonists
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.5.1. Ondansetron
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.5.2. Granisetron
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.6. Cannabinoids
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.7. Others
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7. GLOBAL ANTIEMETICS MARKET, BY DRUG TYPE
7.1. Overview
7.2. Prescription
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.3. OTC
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8. GLOBAL ANTIEMETICS MARKET, BY APPLICATION
8.1. Overview
8.2. Chemotherapy
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8.3. Motion Sickness
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8.4. Stomach Flu
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8.5. Pregnancy
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8.6. Postoperative Surgery
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8.7. Others
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
9. GLOBAL ANTIEMETICS MARKET, BY DISTRIBUTION CHANNEL
9.1. Overview
9.2. Retail Pharmacy
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
9.3. Hospital Pharmacy
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
9.4. Online
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
10. GLOBAL ANTIEMETICS MARKET, BY REGION
10.1. Overview
10.2. Americas
10.2.1. North America
10.2.1.1. US
10.2.1.2. Canada
10.2.2. Latin America
10.3. Europe
10.3.1. Western Europe
10.3.1.1. Germany
10.3.1.2. France
10.3.1.3. Italy
10.3.1.4. Spain
10.3.1.5. UK
10.3.1.6. Rest of Western Europe
10.3.2. Eastern Europe
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle East & Africa
10.5.1. Middle East
10.5.2. Africa
11. COMPANY LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Antiemetics Market
11.5. Competitive Benchmarking
11.6. Leading Players in terms of Number of Developments in the Global Antiemetics Market
11.7. Key developments and Growth Strategies
11.7.1. New Application Launch/Service Deployment
11.7.2. Merger & acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix & Market Ratio
11.8.1. Sales & Operating Income 2023
11.8.2. Major Players R&D Expenditure 2023
11.9. Major Players Capital Market Ratio
12. COMPANY PROFILES
12.1. GSK
12.1.1. Company Overview
12.1.2. Application Type Overview
12.1.3. Financial Overview
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Merck
12.2.1. Company Overview
12.2.2. Application Type Overview
12.2.3. Financial Overview
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Sanofi-Aventis
12.3.1. Company Overview
12.3.2. Application Type Overview
12.3.3. Financial Overview
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Pfizer Inc.
12.4.1. Company Overview
12.4.2. Application Type Overview
12.4.3. Financial Overview
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Mylan
12.5.1. Company Overview
12.5.2. Application Type Overview
12.5.3. Financial Overview
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Eli Lilly and Company
12.6.1. Company Overview
12.6.2. Application Type Overview
12.6.3. Financial Overview
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Johnson & Johnson
12.7.1. Company Overview
12.7.2. Application Type Overview
12.7.3. Financial Overview
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Baxter International
12.8.1. Company Overview
12.8.2. Application Type Overview
12.8.3. Financial Overview
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Dr. Reddy's Laboratories Inc.
12.9.1. Company Overview
12.9.2. Application Type Overview
12.9.3. Financial Overview
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Others
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL ANTIEMETICS MARKET SYNOPSIS, 2023-2032
TABLE 2 GLOBAL ANTIEMETICS MARKET ESTIMATES & FORECAST, 2023-2032(USD MILLION)
TABLE 3 GLOBAL ANTIEMETICS MARKET, BY AGENTS, 2023-2032(USD MILLION)
TABLE 4 GLOBAL ANTIEMETICS MARKET, BY APPLICATION, 2023-2032(USD MILLION)
TABLE 5 GLOBAL ANTIEMETICS MARKET, BY DRUG TYPE, 2023-2032(USD MILLION)
TABLE 6 GLOBAL ANTIEMETICS MARKET, BY DISTRIBUTION CHANNEL, 2023-2032(USD MILLION)
TABLE 7 GLOBAL ANTIEMETICS MARKET, BY REGION, 2023-2032(USD MILLION)
TABLE 8 NORTH AMERICA: ANTIEMETICS MARKET, BY AGENTS, 2023-2032(USD MILLION)
TABLE 9 NORTH AMERICA: ANTIEMETICS MARKET, BY APPLICATION, 2023-2032(USD MILLION)
TABLE 10 NORTH AMERICA: ANTIEMETICS MARKET, BY DRUG TYPE, 2023-2032(USD MILLION)
TABLE 11 NORTH AMERICA: ANTIEMETICS MARKET, BY DISTRIBUTION CHANNEL, 2023-2032(USD MILLION)
TABLE 12 US: ANTIEMETICS MARKET, BY AGENTS, 2023-2032(USD MILLION)
TABLE 13 US: ANTIEMETICS MARKET, BY APPLICATION, 2023-2032(USD MILLION)
TABLE 14 US: ANTIEMETICS MARKET, BY DRUG TYPE, 2023-2032(USD MILLION)
TABLE 15 US: ANTIEMETICS MARKET, BY DISTRIBUTION CHANNEL, 2023-2032(USD MILLION)
TABLE 16 CANADA: ANTIEMETICS MARKET, BY AGENTS, 2023-2032(USD MILLION)
TABLE 17 CANADA: ANTIEMETICS MARKET, BY APPLICATION, 2023-2032(USD MILLION)
TABLE 18 CANADA: ANTIEMETICS MARKET, BY DRUG TYPE, 2023-2032(USD MILLION)
TABLE 19 CANADA: ANTIEMETICS MARKET, BY DISTRIBUTION CHANNEL, 2023-2032(USD MILLION)
TABLE 20 LATIN AMERICA: ANTIEMETICS MARKET, BY AGENTS, 2023-2032(USD MILLION)
TABLE 21 LATIN AMERICA: ANTIEMETICS MARKET, BY APPLICATION, 2023-2032(USD MILLION)
TABLE 22 LATIN AMERICA: ANTIEMETICS MARKET, BY DRUG TYPE, 2023-2032(USD MILLION)
TABLE 23 LATIN AMERICA: ANTIEMETICS MARKET, BY DISTRIBUTION CHANNEL, 2023-2032(USD MILLION)
TABLE 24 EUROPE: ANTIEMETICS MARKET, BY AGENTS, 2023-2032(USD MILLION)
TABLE 25 EUROPE: ANTIEMETICS MARKET, BY APPLICATION, 2023-2032(USD MILLION)
TABLE 26 EUROPE: ANTIEMETICS MARKET, BY DRUG TYPE, 2023-2032(USD MILLION)
TABLE 27 EUROPE: ANTIEMETICS MARKET, BY DISTRIBUTION CHANNEL, 2023-2032(USD MILLION)
TABLE 28 WESTERN EUROPE: ANTIEMETICS MARKET, BY AGENTS, 2023-2032(USD MILLION)
TABLE 29 WESTERN EUROPE: ANTIEMETICS MARKET, BY APPLICATION, 2023-2032(USD MILLION)
TABLE 30 WESTERN EUROPE: ANTIEMETICS MARKET, BY DRUG TYPE, 2023-2032(USD MILLION)
TABLE 31 WESTERN EUROPE: ANTIEMETICS MARKET, BY DISTRIBUTION CHANNEL, 2023-2032(USD MILLION)
TABLE 32 EASTERN EUROPE: ANTIEMETICS MARKET, BY AGENTS, 2023-2032(USD MILLION)
TABLE 33 EASTERN EUROPE: ANTIEMETICS MARKET, BY APPLICATION, 2023-2032(USD MILLION)
TABLE 34 EASTERN EUROPE: ANTIEMETICS MARKET, BY DRUG TYPE, 2023-2032(USD MILLION)
TABLE 35 EASTERN EUROPE: ANTIEMETICS MARKET, BY DISTRIBUTION CHANNEL, 2023-2032(USD MILLION)
TABLE 36 ASIA-PACIFIC: ANTIEMETICS MARKET, BY AGENTS, 2023-2032(USD MILLION)
TABLE 37 ASIA-PACIFIC: ANTIEMETICS MARKET, BY APPLICATION, 2023-2032(USD MILLION)
TABLE 38 ASIA-PACIFIC: ANTIEMETICS MARKET, BY DRUG TYPE, 2023-2032(USD MILLION)
TABLE 39 ASIA-PACIFIC: ANTIEMETICS MARKET, BY DISTRIBUTION CHANNEL, 2023-2032(USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA: ANTIEMETICS MARKET, BY AGENTS, 2023-2032(USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA: ANTIEMETICS MARKET, BY APPLICATION, 2023-2032(USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA: ANTIEMETICS MARKET, BY DRUG TYPE, 2023-2032(USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA: ANTIEMETICS MARKET, BY DISTRIBUTION CHANNEL, 2023-2032(USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCES
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ANTIEMETICS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ANTIEMETICS MARKET
FIGURE 4 GLOBAL ANTIEMETICS MARKET SHARE, BY AGENTS, 2023 (%)
FIGURE 5 GLOBAL ANTIEMETICS MARKET SHARE, BY APPLICATION, 2023 (%)
FIGURE 6 GLOBAL ANTIEMETICS MARKET SHARE, BY DRUG TYPE, 2023 (%)
FIGURE 7 GLOBAL ANTIEMETICS MARKET SHARE, BY DISTRIBUTION CHANNEL, 2023 (%)
FIGURE 8 GLOBAL ANTIEMETICS MARKET SHARE, BY REGION, 2023 (%)
FIGURE 7 AMERICAS: ANTIEMETICS MARKET SHARE BY REGION, 2023 (%)
FIGURE 9 NORTH AMERICA: ANTIEMETICS MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 10 EUROPE: ANTIEMETICS MARKET SHARE, BY REGION, 2023 (%)
FIGURE 11 WESTERN EUROPE: ANTIEMETICS MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 12 ASIA-PACIFIC: ANTIEMETICS MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 13 MIDDLE EAST & AFRICA: ANTIEMETICS MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 14 GLOBAL ANTIEMETICS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 15 GSK: KEY FINANCIALS
FIGURE 16 GSK: SEGMENTAL REVENUE
FIGURE 17 GSK: REGIONAL REVENUE
FIGURE 18 MERCK
FIGURE 19 SANOFI-AVENTIS
FIGURE 20 PFIZER INC.
FIGURE 21 MYLAN
FIGURE 22 ELI LILLY AND COMPANY
FIGURE 23 JOHNSON & JOHNSON
FIGURE 24 BAXTER INTERNATIONAL
FIGURE 25 DR. REDDY'S LABORATORIES INC.